Connect with us

Health

French Senate Rejects Assisted Dying Bill, Sends It Back to Lower House

Published

on

The French Senate on Wednesday rejected a law aimed at regulating assisted dying, sending the bill back to the National Assembly, where it could now be approved without further Senate consent. The proposed legislation would have allowed adults with incurable illnesses to take lethal medication, with assistance from a doctor or nurse only if their physical condition prevented them from doing so themselves.

To qualify, patients must be over 18 and either French citizens or residents of the country. A team of medical professionals would need to confirm that the individual has a grave, incurable illness at an advanced or terminal stage, is experiencing intolerable and untreatable pain, and is seeking lethal medication voluntarily. Patients with severe psychiatric conditions or neurodegenerative disorders, such as Alzheimer’s disease, would not be eligible.

The law would have included a conscience clause for healthcare professionals who object to participating, requiring them to provide patients with names of other practitioners willing to assist.

First proposed in 2024, the bill was approved by the National Assembly in May 2025 before moving to the Senate. However, it was blocked in the upper chamber with 181 votes against and 122 in favour. Critics ranged from right-wing politicians who oppose assisted dying on principle to earlier supporters who considered the final text diluted and insufficient.

On January 21, the Senate rejected Article 4 of the bill, which defined the conditions for medical assistance in dying. The Socialist group in the chamber said the rejection rendered the entire bill “meaningless.” Bruno Retailleau, president of the liberal-conservative Republicans party, argued that instead of new legislation, France should focus on expanding palliative care. “End-of-life care is accompaniment, not abandonment,” Retailleau said on X.

See also  Romania Faces Surging Measles Outbreak Amid Vaccine Hesitancy and Healthcare Challenges

In the same session, the Senate approved a separate law to strengthen access to palliative care across the country. The legislation passed almost unanimously, with 307 votes in favour and 17 against, reflecting broad support for improving end-of-life services.

Yaël Braun-Pivet, president of the National Assembly, expressed regret at the Senate’s rejection but said the process will continue. “As assisted dying responds to a deep-seated desire among the French people, I regret the Senate’s rejection of this bill today,” she said, noting that a second reading in the Assembly is scheduled for the week of February 16. Braun-Pivet predicted the legislation could be definitively adopted by summer 2026, with the Assembly retaining the final say even if the Senate attempts further amendments.

President Emmanuel Macron pledged in 2022 to introduce an assisted dying law following his reelection. France would join Belgium, Luxembourg, the Netherlands, and Spain, where euthanasia is permitted under medical supervision. Austria, Germany, and Italy allow physician-assisted suicide for terminally ill patients, while several other European countries, including Ireland, Cyprus, Malta, Portugal, and Slovenia, are exploring similar legislation.

Health

Wildfire Smoke Poses Growing Air Pollution Risk for Pregnant Women, Study Finds

Published

on

Wildfire smoke is becoming an increasing threat to pregnant women as climate change drives more frequent and intense fires, potentially undermining improvements made in air quality through reductions in pollution from transport and industry.

A new study published in Frontiers in Environmental Health examined exposure to fine particulate matter, known as PM2.5, from wildfires across the United States between 2003 and 2019. Researchers found that prenatal exposure to wildfire smoke more than doubled during the 17-year period.

The increase was particularly significant in western US states, where wildfire seasons have become longer and fires have grown more severe. Researchers found that wildfire smoke was responsible for about 65% of days when air pollution reached levels considered unsafe during pregnancy.

The findings suggest that progress in reducing pollution from human activities is being partly offset by emissions from wildfires.

“Increasing wildfire activity is systematically offsetting prenatal air quality gains,” researchers said, warning that the trend could place a disproportionate burden on low-income, rural and Indigenous communities as wildfire activity continues to intensify.

PM2.5 consists of microscopic particles that can travel deep into the lungs and enter the bloodstream. Exposure during pregnancy has previously been associated with health problems including premature birth and low birth weight.

Researchers also noted that particles produced by wildfires may pose additional risks because their chemical composition can differ from pollution produced by traffic and industrial activity. This could make wildfire smoke particularly concerning for people who are more vulnerable to air pollution.

The findings have implications beyond the United States, as Europe has also experienced increasingly severe wildfire seasons in recent years.

See also  Health Services Scramble During Widespread Blackout in Spain and Portugal

Countries including Greece, Portugal, Spain and France have faced major fires during successive summers, with smoke sometimes spreading across national borders. European climate and health authorities have warned that rising temperatures are contributing to conditions that increase the likelihood and intensity of wildfires.

The growing exposure has raised concerns about how public health systems can protect vulnerable groups as climate-related risks increase.

Experts say governments may need to strengthen guidance for pregnant women and other groups at higher risk from smoke exposure. Measures could include improved wildfire smoke forecasting, earlier health warnings and greater access to clean indoor air during periods of severe pollution.

The research highlights a challenge facing environmental policymakers. While decades of measures have reduced pollution from vehicles, industry and other human activities, climate change is creating additional sources of harmful air pollution.

Continue Reading

Health

Good Sleep May Matter More Than Diet or Exercise for Teenagers’ School Performance

Published

on

Good sleep may have a stronger influence on teenagers’ academic performance and social lives than diet, exercise or screen time, according to new research examining the daily factors that shape young people’s well-being.

The findings suggest that sleep could be particularly important for children experiencing symptoms of depression, anxiety or psychotic-like experiences, which have been linked to difficulties at school and in relationships.

Researchers examined data from more than 6,000 children for academic performance and more than 7,000 for social difficulties. The participants were aged between 10 and 13 and were assessed on four lifestyle factors: sleep quality, screen use, physical activity and diet.

Children showing symptoms of mental health difficulties generally performed worse academically and experienced more social problems. However, researchers found that lifestyle habits appeared to explain a significant part of this relationship, with sleep standing out as the most important factor.

“We expected sleep to be important, but we didn’t expect it to stand out so clearly above other lifestyle factors, particularly screen time,” said Jason Smucny, the study’s lead author at the University of California, Davis.

Researchers said poor sleep can cause daytime tiredness, problems with concentration and weaker executive functioning, all of which can make it harder for students to learn, complete schoolwork and perform well in examinations.

Sleep may also affect relationships. Disrupted or inadequate sleep can contribute to irritability and social withdrawal, potentially making it harder for young people to communicate with friends and maintain healthy relationships.

The researchers said their findings point to sleep quality as an important pathway through which early mental health symptoms can affect everyday functioning.

See also  Study Finds Intensive Blood Pressure Control Reduces Risk of Heart Attack and Stroke

Tara Niendam, the study’s senior author, said parents, teachers and health professionals often concentrate on symptoms such as anxiety and depression, but families are also concerned about how those difficulties affect school performance, friendships and daily activities.

The research suggests that improving sleep routines could be one practical way of supporting young people facing these challenges.

Adolescents have increasingly struggled to get enough sleep, with previous research indicating that teenage sleep levels have declined over recent decades. School demands, social activities, technology use and changing schedules can all interfere with regular sleeping patterns.

The researchers stressed that better sleep cannot address every mental health problem. However, establishing consistent sleep routines may support emotional health and help young people manage the demands of school and social life.

With summer giving students an opportunity to recover from demanding school schedules, the findings highlight the potential importance of using the break to establish healthier and more consistent sleeping habits before the new academic year begins.

Continue Reading

Health

Study Suggests GLP-1 Weight-Loss Drugs May Lower Fracture Risk in People With Type 2 Diabetes

Published

on

A large US study has found that GLP-1 medicines, including widely prescribed treatments such as Ozempic, may reduce the risk of serious bone fractures in people with type 2 diabetes, challenging concerns that rapid weight loss associated with the drugs could weaken bones.

Researchers reported that patients treated with GLP-1 medicines had a 21% lower risk of fragility fractures over a three-year period compared with similar patients who received DPP-4 medicines, another class of drugs commonly used to manage type 2 diabetes.

The findings are based on an analysis of health records from more than 133,000 adults aged between 50 and 90 in the United States who were treated for type 2 diabetes between 2015 and 2022.

People living with type 2 diabetes face a greater risk of fractures caused by low-energy incidents, such as falls from standing height, even though they often have normal or higher-than-average bone density. Researchers said this may be linked to reduced bone strength, changes in bone structure and faster bone loss rather than bone density alone.

The study found the greatest reductions in vertebral fractures, which declined by 32%, while hip and femur fractures fell by 30% among patients taking GLP-1 medicines.

Researchers also noted that the lower fracture risk appeared to be independent of changes in body weight or blood sugar control. This raises the possibility that the medicines may have a direct effect on bone health rather than reducing fractures simply through weight loss or improved diabetes management.

The results challenge long-standing concerns that rapid weight loss could increase fracture risk by reducing bone density. Those concerns have accompanied the growing use of GLP-1 medicines, which have become increasingly popular for treating both type 2 diabetes and obesity.

See also  Study Links Eating Habits to Effectiveness of Popular Weight Loss Drugs

Despite the encouraging findings, the researchers stressed that the study does not establish a direct cause-and-effect relationship. Because the research was based on observational health records rather than a randomized clinical trial, other factors may have influenced the results. Differences in physical activity, muscle strength, nutrition and existing bone health could all have contributed to the lower fracture rates.

The study also found no evidence that GLP-1 medicines reduced fracture risk among people who were taking the drugs without having type 2 diabetes. That suggests the apparent benefit may be specific to patients with diabetes and may not extend to those using the medicines solely for weight management.

The authors said additional prospective clinical trials are needed to confirm whether GLP-1 medicines provide direct protection against fractures and to determine whether any benefits continue during longer periods of treatment.

The findings add to growing research into the wider health effects of GLP-1 medicines as their use continues to expand around the world for diabetes care and weight management.

Continue Reading

Trending